"

From 2012.igem.org

Contents 1 Cowpea Chlorotic Mottle Virus 1.1 VLP 1.2 Methods 1.3 Part 1: Modifying the CCMV VLP for site specific drug delivery 1.3.1 Introduction 1.3.2 Outside modification of CCMV VLP 1.3.3 inside modification of CCMV VLP

Cowpea Chlorotic Mottle Virus

CCMV is the abbreviation of Cowpea Chlorotic Mottle Virus, and is a well studied black eyed pea infecting virus. It is a virus in the family Bromoviridae, and it is one of the most studied plant viruses. As from the discovery of the virus in 1967, it was an interesting virus due to the easy cultivation and harvesting procedures involved. Interest in this virus is especially in the ability to disassemble the virus, remove the content and refold the empty particle simply by altering the pH. This makes this virus one of the first and best studied Virus Like Particles.

VLP

The idea of disassembly and reassembly of CCMV into VLPs did not stop by the formation of empty particles. Little inorganic crystals and proteins were also able to be captured into the shell. The production of these VLPs can also be integrated into a synthetic biology approach. Expression of only the coat protein in ‘’Escherichia coli’’ or yeast could also provide the coat proteins that are able to assemble and reassemble when playing with the pH. This way however opened the interest of a whole new kind of applications for these VLPs, naming medical applications. This is because this synthetic approach removes the pathogenic factor, the virus, from the production process. This assists in the acceptance of these kind of particles in the application of treating (plant)-diseases.

Methods

The template of the CCMV coat protein was provided by the Virology group Wageningen, in a pET28 vector, a normal ‘’E. coli’’ expression vector. We used primers that already included the prefix and suffix of Standard 10, so that after amplification, the gene can be directly ligated into a pSB1C3 backbone. It also allows the combination with an inducible promoter and RBS directly. In order to make the modified VLPs, we designed primers with an overhang containing the modifications. A detailed description of the primers and the modifications can be found in the Journal.

Part 1: Modifying the CCMV VLP for site specific drug delivery

Introduction

CCMV will be one of the VLPs that we will be working on. We will focus on this VLP to prove the concept of using it as a Drug Delivery System.

Aim: Producing CCMV VLPs with epitopes on the outside or packaging coils in the inside, with the possibility to combine both to deliver a bio Nano carrier, with ligands on the outside and “medicine” packed on the inside.

Outside modification of CCMV VLP

inside modification of CCMV VLP